Table 4.
Drug | Treatment / Route | Cmax (μg/ml) | t½ (hrs) | AUC0→inf (μg/ml*hr) |
---|---|---|---|---|
Fasudil | Plain IV | 3.83±0.29 | 0.57±0.03 | 7.17±3.42 |
Plain IT | 1.64±0.31 | 1.49±0.09 | 15.62±4.21 | |
Plain combination IT | 1.59±0.45 | 1.52±0.05 | 16.83±3.99 | |
Liposomes IT | 0.79±0.25 | 4.21±0.17 | 14.01±3.27 | |
CAR-Liposomes IT | 0.74±0.37 | 4.53±0.26 | 13.85±5.82 | |
SOD | Plain IV | 5.78±0.24 | 0.89±0.04 | 9.31±2.75 |
Plain IT | 1.45±0.28 | 2.24±0.03 | 27.78±6.91 | |
Plain combination IT | 1.41±0.57 | 2.35±0.08 | 27.69±8.19 | |
Liposomes IT | 0.83±0.27 | 6.32±0.29 | 18.41±9.81 | |
CAR-Liposomes IT | 0.77±0.19 | 6.75±0.18 | 19.75±5.28 |
Data represent mean ± standard deviation (n=3).